New virus injection trial offers hope for Tough-to-Treat cancer
Disease control
Recruiting now
This study is testing a new two-part treatment for advanced angiosarcoma, a rare and aggressive cancer. It combines a modified virus injected directly into tumors with a standard immunotherapy drug. The goal is to see if this combination is safe and can shrink tumors in patients …
Phase: PHASE2 • Sponsor: Varun Monga, MBBS • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC